Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 311

1.

The vasa vasorum reach deep into the human thoracic aorta.

Federspiel JM, Tschernig T, Laschke MW, Wagenpfeil S, Schnabel P, Schäfers HJ.

Ann Anat. 2019 Sep;225:54-56. doi: 10.1016/j.aanat.2019.06.001. Epub 2019 Jul 6.

PMID:
31288081
2.

Impact of EMT in stage IIIB/IV NSCLC treated with erlotinib and bevacizumab when compared with cisplatin, gemcitabine and bevacizumab.

Villalobos M, Czapiewski P, Reinmuth N, Fischer JR, Andreas S, Kortsik C, Serke M, Wolf M, Neuser P, Reuss A, Schnabel PA, Thomas M.

Oncol Lett. 2019 Jun;17(6):4891-4900. doi: 10.3892/ol.2019.10153. Epub 2019 Mar 15.

3.

Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.

Becker N, Motsch E, Trotter A, Heussel CP, Dienemann H, Schnabel PA, Kauczor HU, Maldonado SG, Miller AB, Kaaks R, Delorme S.

Int J Cancer. 2020 Mar 15;146(6):1503-1513. doi: 10.1002/ijc.32486. Epub 2019 Jun 20.

PMID:
31162856
4.

Targeting LINC00673 expression triggers cellular senescence in lung cancer.

Roth A, Boulay K, Groß M, Polycarpou-Schwarz M, Mallette FA, Regnier M, Bida O, Ginsberg D, Warth A, Schnabel PA, Muley T, Meister M, Zabeck H, Hoffmann H, Diederichs S.

RNA Biol. 2018;15(12):1499-1511. doi: 10.1080/15476286.2018.1553481. Epub 2018 Dec 7.

5.

Molecular signatures in IASLC/ATS/ERS classified growth patterns of lung adenocarcinoma.

Zabeck H, Dienemann H, Hoffmann H, Pfannschmidt J, Warth A, Schnabel PA, Muley T, Meister M, Sültmann H, Fröhlich H, Kuner R, Lasitschka F.

PLoS One. 2018 Oct 23;13(10):e0206132. doi: 10.1371/journal.pone.0206132. eCollection 2018.

6.

ERCC1 assessment in upfront treatment with and without cisplatin-based chemotherapy in stage IIIB/IV non-squamous non-small cell lung cancer.

Villalobos M, Czapiewski P, Reinmuth N, Fischer JR, Andreas S, Kortsik C, Serke M, Wolf M, Neuser P, Reuss A, Schnabel PA, Thomas M.

Med Oncol. 2018 Jun 15;35(7):106. doi: 10.1007/s12032-018-1169-5.

PMID:
29905882
7.

Large cell neuroendocrine lung carcinoma induces peripheral T-cell repertoire alterations with predictive and prognostic significance.

Christopoulos P, Schneider MA, Bozorgmehr F, Kuon J, Engel-Riedel W, Kollmeier J, Baum V, Muley T, Schnabel PA, Bischoff H, Grohé C, Serke M, Thomas M, Fisch P, Meister M.

Lung Cancer. 2018 May;119:48-55. doi: 10.1016/j.lungcan.2018.03.002. Epub 2018 Mar 6.

PMID:
29656752
8.

A Flat Tire in the Colon.

Zimmer V, Schnabel PA, Lammert F.

Gastroenterology. 2018 Feb;154(3):e8-e9. doi: 10.1053/j.gastro.2017.05.023. Epub 2018 Jan 18. No abstract available.

PMID:
29352959
9.

CT characteristics in pulmonary adenocarcinoma with epidermal growth factor receptor mutation.

Zhao J, Dinkel J, Warth A, Penzel R, Reinmuth N, Schnabel P, Muley T, Meister M, Zabeck H, Steins M, Yang JY, Zhou Q, Schlemmer HP, Herth FJF, Kauczor HU, Heussel CP.

PLoS One. 2017 Sep 26;12(9):e0182741. doi: 10.1371/journal.pone.0182741. eCollection 2017.

10.

Confocal microscopy as an early relapse marker for acanthamoeba keratitis.

Daas L, Viestenz A, Schnabel PA, Fries FN, Hager T, SzentmÁry N, Seitz B.

Clin Anat. 2018 Jan;31(1):60-63. doi: 10.1002/ca.22925. Epub 2017 Jul 27.

PMID:
28556202
11.

Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma: a multicenter phase II trial.

Christopoulos P, Engel-Riedel W, Grohé C, Kropf-Sanchen C, von Pawel J, Gütz S, Kollmeier J, Eberhardt W, Ukena D, Baum V, Nimmrich I, Sieder C, Schnabel PA, Serke M, Thomas M.

Ann Oncol. 2017 Aug 1;28(8):1898-1902. doi: 10.1093/annonc/mdx268.

12.

Nontypeable Haemophilus influenzae-Promoted Proliferation of Kras-Induced Early Adenomatous Lesions Is Completely Dependent on Toll-Like Receptor Signaling.

Jungnickel C, Schnabel PA, Bohle R, Wiewrodt R, Herr C, Bals R, Beisswenger C.

Am J Pathol. 2017 May;187(5):973-979. doi: 10.1016/j.ajpath.2017.01.003. Epub 2017 Mar 6.

13.

Thoracic oncology HERMES: European curriculum recommendations for training in thoracic oncology.

Gamarra F, Noël JL, Brunelli A, Dingemans AC, Felip E, Gaga M, Grigoriu BD, Hardavella G, Huber RM, Janes S, Massard G, Putora PM, Sculier JP, Schnabel PA, Ramella S, Van Raemdonck D, Meert AP.

Breathe (Sheff). 2016 Sep;12(3):249-255. doi: 10.1183/20734735.009116. Review.

14.

[Grading of neuroendocrine tumors].

Saeger W, Schnabel PA, Komminoth P.

Pathologe. 2016 Jul;37(4):304-13. doi: 10.1007/s00292-016-0186-4. Review. German.

PMID:
27379621
15.

[Grading of lung cancer].

Bohle RM, Schnabel PA.

Pathologe. 2016 Jul;37(4):314-9. doi: 10.1007/s00292-016-0175-7. Review. German.

PMID:
27356985
16.

[Application and interpretation of the R classification for lung cancer : Results of a survey of certified lung cancer centers].

Hoffmann H, Junker K, Kugler C, Schnabel PA, Warth A.

Pathologe. 2016 May;37(3):258-68. doi: 10.1007/s00292-016-0141-4. German.

PMID:
27091658
17.

Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response in upper GI cancers.

Brücher BL, Li Y, Schnabel P, Daumer M, Wallace TJ, Kube R, Zilberstein B, Steele S, Voskuil JL, Jamall IS.

Clin Transl Med. 2016 Mar;5(1):13. doi: 10.1186/s40169-016-0093-6. Epub 2016 Apr 6. Review.

18.

Myocardial Perfusion Reserve and Strain-Encoded CMR for Evaluation of Cardiac Allograft Microvasculopathy.

Erbel C, Mukhammadaminova N, Gleissner CA, Osman NF, Hofmann NP, Steuer C, Akhavanpoor M, Wangler S, Celik S, Doesch AO, Voss A, Buss SJ, Schnabel PA, Katus HA, Korosoglou G.

JACC Cardiovasc Imaging. 2016 Mar;9(3):255-66. doi: 10.1016/j.jcmg.2015.10.012.

19.

Phospholipid profiling identifies acyl chain elongation as a ubiquitous trait and potential target for the treatment of lung squamous cell carcinoma.

Marien E, Meister M, Muley T, Gomez Del Pulgar T, Derua R, Spraggins JM, Van de Plas R, Vanderhoydonc F, Machiels J, Binda MM, Dehairs J, Willette-Brown J, Hu Y, Dienemann H, Thomas M, Schnabel PA, Caprioli RM, Lacal JC, Waelkens E, Swinnen JV.

Oncotarget. 2016 Mar 15;7(11):12582-97. doi: 10.18632/oncotarget.7179.

20.

Non-small cell lung cancer patients with brain metastases treated with first-line platinum-doublet chemotherapy: Analysis from the European FRAME study.

Moro-Sibilot D, Smit E, de Castro Carpeño J, Lesniewski-Kmak K, Aerts JG, Villatoro R, Kraaij K, Nacerddine K, Dyachkova Y, Smith KT, Girvan A, Visseren-Grul C, Schnabel PA.

Lung Cancer. 2015 Dec;90(3):427-32. doi: 10.1016/j.lungcan.2015.11.011. Epub 2015 Nov 10.

PMID:
26791802
21.

Cisplatin and carboplatin-based chemotherapy in the first-line treatment of non-small cell lung cancer: Analysis from the European FRAME study.

Smit E, Moro-Sibilot D, Carpeño Jde C, Lesniewski-Kmak K, Aerts J, Villatoro R, Kraaij K, Nacerddine K, Dyachkova Y, Smith KT, Girvan A, Visseren-Grul C, Schnabel PA.

Lung Cancer. 2016 Feb;92:35-40. doi: 10.1016/j.lungcan.2015.11.022. Epub 2015 Dec 3.

PMID:
26775594
22.

Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC).

Rieber J, Deeg A, Ullrich E, Foerster R, Bischof M, Warth A, Schnabel PA, Muley T, Kappes J, Heussel CP, Welzel T, Thomas M, Steins M, Dienemann H, Debus J, Hoffmann H, Rieken S.

Lung Cancer. 2016 Jan;91:41-7. doi: 10.1016/j.lungcan.2015.11.014. Epub 2015 Nov 25.

PMID:
26711933
23.

Same-sex sexuality and psychiatric disorders in the second Netherlands Mental Health Survey and Incidence Study (NEMESIS-2).

Sandfort TG, de Graaf R, Ten Have M, Ransome Y, Schnabel P.

LGBT Health. 2014 Dec;1(4):292-301. Epub 2014 Oct 16.

24.

Comprehensive genomic profiles of small cell lung cancer.

George J, Lim JS, Jang SJ, Cun Y, Ozretić L, Kong G, Leenders F, Lu X, Fernández-Cuesta L, Bosco G, Müller C, Dahmen I, Jahchan NS, Park KS, Yang D, Karnezis AN, Vaka D, Torres A, Wang MS, Korbel JO, Menon R, Chun SM, Kim D, Wilkerson M, Hayes N, Engelmann D, Pützer B, Bos M, Michels S, Vlasic I, Seidel D, Pinther B, Schaub P, Becker C, Altmüller J, Yokota J, Kohno T, Iwakawa R, Tsuta K, Noguchi M, Muley T, Hoffmann H, Schnabel PA, Petersen I, Chen Y, Soltermann A, Tischler V, Choi CM, Kim YH, Massion PP, Zou Y, Jovanovic D, Kontic M, Wright GM, Russell PA, Solomon B, Koch I, Lindner M, Muscarella LA, la Torre A, Field JK, Jakopovic M, Knezevic J, Castaños-Vélez E, Roz L, Pastorino U, Brustugun OT, Lund-Iversen M, Thunnissen E, Köhler J, Schuler M, Botling J, Sandelin M, Sanchez-Cespedes M, Salvesen HB, Achter V, Lang U, Bogus M, Schneider PM, Zander T, Ansén S, Hallek M, Wolf J, Vingron M, Yatabe Y, Travis WD, Nürnberg P, Reinhardt C, Perner S, Heukamp L, Büttner R, Haas SA, Brambilla E, Peifer M, Sage J, Thomas RK.

Nature. 2015 Aug 6;524(7563):47-53. doi: 10.1038/nature14664. Epub 2015 Jul 13.

25.

Application in Europe of a urine-based rapid diagnostic test for confirmation of Schistosoma mansoni infection in migrants from endemic areas.

Becker SL, Marti H, Zimmermann S, Vidacek D, Herrmann M, Utzinger J, Schnabel PA, Bohle RM.

Euro Surveill. 2015 Jun 11;20(23). pii: 21151.

26.

[Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].

Schnabel PA, Junker K.

Pathologe. 2015 May;36(3):283-92. doi: 10.1007/s00292-015-0030-2. Review. German.

PMID:
25956813
27.

Glycodelin: A New Biomarker with Immunomodulatory Functions in Non-Small Cell Lung Cancer.

Schneider MA, Granzow M, Warth A, Schnabel PA, Thomas M, Herth FJ, Dienemann H, Muley T, Meister M.

Clin Cancer Res. 2015 Aug 1;21(15):3529-40. doi: 10.1158/1078-0432.CCR-14-2464. Epub 2015 Apr 21.

28.

Erlotinib and bevacizumab versus cisplatin, gemcitabine and bevacizumab in unselected nonsquamous nonsmall cell lung cancer.

Thomas M, Fischer J, Andreas S, Kortsik C, Grah C, Serke M, von Eiff M, Witt C, Kollmeier J, Müller E, Schenk M, Schröder M, Villalobos M, Reinmuth N, Penzel R, Schnabel P, Acker T, Reuss A, Wolf M; ABC-Lung Cancer Group.

Eur Respir J. 2015 Jul;46(1):219-29. doi: 10.1183/09031936.00229014. Epub 2015 Mar 18.

29.

Non-small cell lung cancer is characterized by dramatic changes in phospholipid profiles.

Marien E, Meister M, Muley T, Fieuws S, Bordel S, Derua R, Spraggins J, Van de Plas R, Dehairs J, Wouters J, Bagadi M, Dienemann H, Thomas M, Schnabel PA, Caprioli RM, Waelkens E, Swinnen JV.

Int J Cancer. 2015 Oct 1;137(7):1539-48. doi: 10.1002/ijc.29517. Epub 2015 Apr 7.

30.

Randomized Study on Early Detection of Lung Cancer with MSCT in Germany: Results of the First 3 Years of Follow-up After Randomization.

Becker N, Motsch E, Gross ML, Eigentopf A, Heussel CP, Dienemann H, Schnabel PA, Eichinger M, Optazaite DE, Puderbach M, Wielpütz M, Kauczor HU, Tremper J, Delorme S.

J Thorac Oncol. 2015 Jun;10(6):890-6. doi: 10.1097/JTO.0000000000000530.

31.

Niemann-Pick Type C-2 Disease: Identification by Analysis of Plasma Cholestane-3β,5α,6β-Triol and Further Insight into the Clinical Phenotype.

Reunert J, Lotz-Havla AS, Polo G, Kannenberg F, Fobker M, Griese M, Mengel E, Muntau AC, Schnabel P, Sommerburg O, Borggraefe I, Dardis A, Burlina AP, Mall MA, Ciana G, Bembi B, Burlina AB, Marquardt T.

JIMD Rep. 2015;23:17-26. doi: 10.1007/8904_2015_423. Epub 2015 Mar 13.

32.

Outcomes and resource use of non-small cell lung cancer (NSCLC) patients treated with first-line platinum-based chemotherapy across Europe: FRAME prospective observational study.

Moro-Sibilot D, Smit E, de Castro Carpeño J, Lesniewski-Kmak K, Aerts J, Villatoro R, Kraaij K, Nacerddine K, Dyachkova Y, Smith KT, Taipale K, Girvan AC, Visseren-Grul C, Schnabel PA.

Lung Cancer. 2015 May;88(2):215-22. doi: 10.1016/j.lungcan.2015.02.011. Epub 2015 Feb 21.

PMID:
25748103
33.

Hypoxic epithelial necrosis triggers neutrophilic inflammation via IL-1 receptor signaling in cystic fibrosis lung disease.

Fritzsching B, Zhou-Suckow Z, Trojanek JB, Schubert SC, Schatterny J, Hirtz S, Agrawal R, Muley T, Kahn N, Sticht C, Gunkel N, Welte T, Randell SH, Länger F, Schnabel P, Herth FJ, Mall MA.

Am J Respir Crit Care Med. 2015 Apr 15;191(8):902-13. doi: 10.1164/rccm.201409-1610OC.

34.

Treatment and outcome of lung cancer in idiopathic interstitial pneumonias.

Kreuter M, Ehlers-Tenenbaum S, Schaaf M, Oltmanns U, Palmowski K, Hoffmann H, Schnabel PA, Heußel CP, Puderbach M, Herth FJ, Warth A.

Sarcoidosis Vasc Diffuse Lung Dis. 2015 Jan 5;31(4):266-74.

PMID:
25591137
35.

Invasive lung cancer staging: influence of CT-guided core needle biopsy on onset of pleural carcinomatosis.

Flechsig P, Kunz J, Heussel CP, Bozorgmehr F, Schnabel P, Dienemann H, Kauczor HU, Sedlaczek O.

Clin Imaging. 2015 Jan-Feb;39(1):56-61. doi: 10.1016/j.clinimag.2014.10.005. Epub 2014 Oct 16.

PMID:
25457543
36.

[Neuroendocrine tumors of the lungs. From small cell lung carcinoma to diffuse idiopathic pulmonary neuroendocrine cell hyperplasia].

Schnabel PA, Junker K.

Pathologe. 2014 Nov;35(6):557-64. doi: 10.1007/s00292-014-1917-z. Review. German.

PMID:
25366372
37.

The "Wagshurst study": p.Val40Ile transthyretin gene variant causes late-onset cardiomyopathy.

Bauer R, Dikow N, Brauer A, Kreuter M, Buss S, Evers C, Röcken C, Schnabel PA, Hinderhofer K, Ehlermann P, Katus HA, Kristen AV.

Amyloid. 2014 Dec;21(4):267-75. doi: 10.3109/13506129.2014.967846. Epub 2014 Oct 7.

PMID:
25291558
38.

T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy.

aus dem Siepen F, Buss SJ, Messroghli D, Andre F, Lossnitzer D, Seitz S, Keller M, Schnabel PA, Giannitsis E, Korosoglou G, Katus HA, Steen H.

Eur Heart J Cardiovasc Imaging. 2015 Feb;16(2):210-6. doi: 10.1093/ehjci/jeu183. Epub 2014 Sep 22.

PMID:
25246502
39.

Correlation of EGFR expression, gene copy number and clinicopathological status in NSCLC.

Gaber R, Watermann I, Kugler C, Reinmuth N, Huber RM, Schnabel PA, Vollmer E, Reck M, Goldmann T.

Diagn Pathol. 2014 Sep 17;9:165. doi: 10.1186/s13000-014-0165-0.

40.

Pirfenidone in idiopathic pulmonary fibrosis: real-life experience from a German tertiary referral center for interstitial lung diseases.

Oltmanns U, Kahn N, Palmowski K, Träger A, Wenz H, Heussel CP, Schnabel PA, Puderbach M, Wiebel M, Ehlers-Tenenbaum S, Warth A, Herth FJ, Kreuter M.

Respiration. 2014;88(3):199-207. doi: 10.1159/000363064. Epub 2014 Aug 9.

41.

Evaluation of the clinical use of midregional pro-atrial natriuretic peptide (MR-proANP) in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP) for risk stratification in patients with light-chain amyloidosis.

Kristen AV, Biener M, Hegenbart U, Hardt S, Schnabel PA, Röcken C, Schonland SO, Katus HA, Giannitsis E.

Int J Cardiol. 2014 Oct 20;176(3):1113-5. doi: 10.1016/j.ijcard.2014.07.106. Epub 2014 Aug 1. No abstract available.

PMID:
25115253
42.

Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role.

Warth A, Cortis J, Soltermann A, Meister M, Budczies J, Stenzinger A, Goeppert B, Thomas M, Herth FJ, Schirmacher P, Schnabel PA, Hoffmann H, Dienemann H, Muley T, Weichert W.

Br J Cancer. 2014 Sep 9;111(6):1222-9. doi: 10.1038/bjc.2014.402. Epub 2014 Jul 22.

43.

Osteopontin: a novel predictor of survival in patients with systemic light-chain amyloidosis.

Kristen AV, Rosenberg M, Lindenmaier D, Merkle C, Steen H, Andre F, Schönland SO, Schnabel PA, Schuster T, Röcken C, Giannitsis E, Katus HA, Frey N.

Amyloid. 2014 Sep;21(3):202-10. doi: 10.3109/13506129.2014.940457. Epub 2014 Jul 9.

PMID:
25007036
44.

Comparison of two ERCC1 antibodies as prognostic and predictive biomarkers for early non-small cell lung cancer.

Muley TR, Sianidou M, Thomas M, Bischoff H, Dienemann H, Meister M, Schneider MA, Schnabel PA, Warth A.

Anticancer Res. 2014 Jul;34(7):3707-13.

PMID:
24982391
45.

Morphological computed tomography features of surgically resectable pulmonary squamous cell carcinomas: impact on prognosis and comparison with adenocarcinomas.

Koenigkam Santos M, Muley T, Warth A, de Paula WD, Lederlin M, Schnabel PA, Schlemmer HP, Kauczor HU, Heussel CP, Puderbach M.

Eur J Radiol. 2014 Jul;83(7):1275-1281. doi: 10.1016/j.ejrad.2014.04.019. Epub 2014 May 1.

PMID:
24840477
46.

Characteristics of lung cancer after a previous malignancy.

Reinmuth N, Stumpf P, Stumpf A, Muley T, Kobinger S, Hoffmann H, Herth FJ, Schnabel PA, Bischoff H, Thomas M.

Respir Med. 2014 Jun;108(6):910-7. doi: 10.1016/j.rmed.2014.02.015. Epub 2014 Mar 5.

47.

Open, randomized, multi-center phase II study comparing efficacy and tolerability of Erlotinib vs. Carboplatin/Vinorelbin in elderly patients (>70 years of age) with untreated non-small cell lung cancer.

Heigener DF, Deppermann KM, Pawel JV, Fischer JR, Kortsik C, Bohnet S, Eiff MV, Koester W, Thomas M, Schnabel PA, Reck M.

Lung Cancer. 2014 Apr;84(1):62-6. doi: 10.1016/j.lungcan.2014.01.024. Epub 2014 Feb 3.

PMID:
24560332
48.

Preparation of cell blocks for lung cancer diagnosis and prediction: protocol and experience of a high-volume center.

Kossakowski CA, Morresi-Hauf A, Schnabel PA, Eberhardt R, Herth FJ, Warth A.

Respiration. 2014;87(5):432-8. doi: 10.1159/000357068. Epub 2014 Jan 16.

49.

ROS1 expression and translocations in non-small-cell lung cancer: clinicopathological analysis of 1478 cases.

Warth A, Muley T, Dienemann H, Goeppert B, Stenzinger A, Schnabel PA, Schirmacher P, Penzel R, Weichert W.

Histopathology. 2014 Aug;65(2):187-94. doi: 10.1111/his.12379. Epub 2014 Apr 3.

PMID:
24456475
50.

Anti-Apoptotic Signature in Thymic Squamous Cell Carcinomas - Functional Relevance of Anti-Apoptotic BIRC3 Expression in the Thymic Carcinoma Cell Line 1889c.

Huang B, Belharazem D, Li L, Kneitz S, Schnabel PA, Rieker RJ, Körner D, Nix W, Schalke B, Müller-Hermelink HK, Ott G, Rosenwald A, Ströbel P, Marx A.

Front Oncol. 2013 Dec 31;3:316. doi: 10.3389/fonc.2013.00316. eCollection 2013.

Supplemental Content

Loading ...
Support Center